sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseMedical Devices

Dynamic Blood Pressure Monitor Market Set for 7.65% Growth to USD 1857 million by 2034

North America leads with 34% of 2025 revenue, while Mobile-based ABPM grows fastest at 10.87% across the forecast period.

PUNE, INDIA — 21 AUGUST 2026CONTRIVE DATUM INSIGHTS

From USD 960 million in 2025 to USD 1857 million in 2034, a 7.65% compound annual rate.

34% of 2025 revenue (USD 326.4 million) is generated in North America.

Mobile-based ABPM is the fastest-growing line at 10.87% annually.

58% of 2025 revenue sits in Ordinary ABPM, the largest type line.

Contrive Datum Insights has published "Dynamic Blood Pressure Monitor Market Size, Share & Industry Analysis, By Type (Ordinary ABPM, Mobile-based ABPM), Application (Hospital, Clinic, Other), End user (Hospitals, Homecare Settings, Diagnostic Centers), Component (Devices, Software and Analysis Platforms), Distribution channel (Direct Tender, Retail Pharmacy, Online Channels), and Regional Forecast, 2026-2034". The study sizes the global dynamic blood pressure monitor market at USD 960 million in 2025 and projects growth from USD 1030 million in 2026 to USD 1857 million by 2034, a compound annual growth rate of 7.65% across the forecast period.

A dynamic, or ambulatory, blood pressure monitor is a wearable diagnostic device that automatically records a patient's blood pressure at set intervals across a full day and night while the wearer continues normal activity, rather than relying on a single in-clinic reading. The category spans ordinary cuff-based units that store the recording for later download and mobile-based units that transmit readings to a connected application or clinical platform as they are taken. It is bought by hospitals, cardiology and hypertension specialty clinics, diagnostic centers, and home healthcare providers seeking a more representative view of a patient's blood pressure pattern than an office visit alone can give.

Rising global hypertension prevalence expanding the diagnosed and monitored patient pool

Rising global hypertension prevalence expanding the diagnosed and monitored patient pool is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.65% a year, the type lines exposed to it move fastest: Mobile-based ABPM compounds at 10.87%, taking its share of revenue from 42% to 55% and its value from USD 403.2 million to USD 1021.35 million.

On the upside, the study's bull case assumes bull case assumes faster-than-expected reimbursement expansion for home and ambulatory monitoring across major markets, pulling forward adoption of mobile-based ABPM among both hospitals and homecare patients, which would take 2034 revenue to USD 2079.8 million rather than the USD 1857 million base case.

However, bear case assumes reimbursement expansion stalls in several major markets and device replacement cycles lengthen as cost pressure on hospital and clinic procurement budgets persists, which would hold 2034 revenue to USD 1634.2 million. Ordinary ABPM, which carries 58% of 2025 revenue, already grows at only 4.62% against the market's 7.65%, so the largest part of the base is also its slowest.

Key Players Compete on Ordinary ABPM Volume and Mobile-based ABPM Growth

Competition in the global dynamic blood pressure monitor market runs along the type axis rather than the regional one. Ordinary ABPM holds 58% of 2025 revenue at USD 556.8 million and remains the largest line through 2034 at 45%, making it the position hardest for a challenger to take. Mobile-based ABPM, growing at 10.87%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 960 million.

Further Report Findings

SegmentLed 2025 byShare & valueFastest-growing
TypeOrdinary ABPM58% · USD 556.8 million
ApplicationHospital55% · USD 528 millionOther 9.12%
End userHospitals48% · USD 460.8 millionHomecare Settings 9.68%
ComponentDevices78% · USD 748.8 millionSoftware and Analysis Platforms 12.18%
Distribution channelDirect Tender50% · USD 480 millionOnline Channels 12.81%
  • Based on regional analysis, North America led the global dynamic blood pressure monitor market in 2025 with 34% of global revenue at USD 326.4 million, reaching USD 557.1 million by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 28% in 2025 to 33% in 2034, with revenue growing from USD 268.8 million to USD 612.81 million.
  • Middle East and Africa remains the smallest region throughout, at 5% of 2025 revenue and 5% by 2034.
  • Mobile-based ABPM is projected to grow at 10.87% over the forecast period, the fastest of any type line.
  • The United States is the largest single country market at USD 221.95 million in 2025, 23.12% of global revenue.

The report segments the market across five axes; by type, and by application, end user, component and distribution channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 1634.2 million and USD 2079.8 million by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078